Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Mutational hotspots in the mitochondrial genome of lung cancer.

Choi SJ, Kim SH, Kang HY, Lee J, Bhak JH, Sohn I, Jung SH, Choi YS, Kim HK, Han J, Huh N, Lee G, Kim BC, Kim J.

Biochem Biophys Res Commun. 2011 Apr 1;407(1):23-7. doi: 10.1016/j.bbrc.2011.02.078. Epub 2011 Feb 18.

PMID:
21334307
2.

mtDNA variations other than point mutations may also have a role in carcinogenesis of lung cancer.

Kurt YG, Cayci T, Akgul EO, Kurt B.

Biochem Biophys Res Commun. 2012 Apr 13;420(3):698. doi: 10.1016/j.bbrc.2012.03.115. Epub 2012 Mar 26. No abstract available.

PMID:
22459215
3.
4.

High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.

Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H.

Cancer Res. 1998 Jan 15;58(2):328-33.

5.

EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.

Bae NC, Chae MH, Lee MH, Kim KM, Lee EB, Kim CH, Park TI, Han SB, Jheon S, Jung TH, Park JY.

Cancer Genet Cytogenet. 2007 Mar;173(2):107-13.

PMID:
17321325
6.

Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.

Gao WM, Romkes M, Day RD, Siegfried JM, Luketich JD, Mady HH, Melhem MF, Keohavong P.

Carcinogenesis. 2003 Oct;24(10):1671-6. Epub 2003 Jul 4.

PMID:
12844488
7.

A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.

Sarkar FH, Valdivieso M, Borders J, Yao KL, Raval MM, Madan SK, Sreepathi P, Shimoyama R, Steiger Z, Visscher DW, et al.

Diagn Mol Pathol. 1995 Dec;4(4):266-73.

PMID:
8634783
8.

[Epidermal growth factor receptor mutation in Chinese patients with non-small cell lung cancer].

Pan ZK, Zhang L, Zhang X, Wang X, Li N, Xu F, Chang JH, Guan ZZ.

Ai Zheng. 2005 Aug;24(8):919-23. Chinese.

PMID:
16086866
9.

The pattern of natural selection in somatic cancer mutations of human mtDNA.

Stafford P, Chen-Quin EB.

J Hum Genet. 2010 Sep;55(9):605-12. doi: 10.1038/jhg.2010.76. Epub 2010 Jul 8.

PMID:
20613764
10.

Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.

Medina PP, Carretero J, Fraga MF, Esteller M, Sidransky D, Sanchez-Cespedes M.

Genes Chromosomes Cancer. 2004 Oct;41(2):170-7. Erratum in: Genes Chromosomes Cancer. 2005 Feb;42(2):211.

PMID:
15287030
11.

Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer.

Ahrendt SA, Chow JT, Yang SC, Wu L, Zhang MJ, Jen J, Sidransky D.

Cancer Res. 2000 Jun 15;60(12):3155-9.

12.

[Analysis of EGFR mutations in 176 cases of non-small cell lung cancer].

Dong QG, Han BH, Huang JS, Yang LM, Huang J, Zhao CY, Lu LQ.

Zhonghua Zhong Liu Za Zhi. 2006 Sep;28(9):686-90. Chinese.

PMID:
17274376
13.

Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.

Tam IY, Chung LP, Suen WS, Wang E, Wong MC, Ho KK, Lam WK, Chiu SW, Girard L, Minna JD, Gazdar AF, Wong MP.

Clin Cancer Res. 2006 Mar 1;12(5):1647-53.

14.

Distribution of p53 and K-ras mutations in human lung cancer tissues.

Gao HG, Chen JK, Stewart J, Song B, Rayappa C, Whong WZ, Ong T.

Carcinogenesis. 1997 Mar;18(3):473-8.

PMID:
9067544
15.

Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.

Szymanowska A, Jassem E, Dziadziuszko R, Borg A, Limon J, Kobierska-Gulida G, Rzyman W, Jassem J.

Lung Cancer. 2006 Apr;52(1):9-14. Epub 2006 Feb 24.

PMID:
16499995
16.

[Detection of epidermal growth factor receptor mutations in non-small cell lung cancer by real-time PCR using TaqMan-MGB probes].

Zhou CC, Zhou SW, Pan H, Su B, Gao ZQ.

Zhonghua Zhong Liu Za Zhi. 2007 Feb;29(2):119-23. Chinese.

PMID:
17645848
17.

Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer.

Gemma A, Seike M, Seike Y, Uematsu K, Hibino S, Kurimoto F, Yoshimura A, Shibuya M, Harris CC, Kudoh S.

Genes Chromosomes Cancer. 2000 Nov;29(3):213-8.

PMID:
10992296
18.

TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.

de Anta JM, Jassem E, Rosell R, Martínez-Roca M, Jassem J, Martínez-López E, Monzó M, Sánchez-Hernández JJ, Moreno I, Sánchez-Céspedes M.

Oncogene. 1997 Dec 11;15(24):2951-8.

19.

TP53 mutation, allelism and survival in non-small cell lung cancer.

Nelson HH, Wilkojmen M, Marsit CJ, Kelsey KT.

Carcinogenesis. 2005 Oct;26(10):1770-3. Epub 2005 May 19.

PMID:
15905205
20.

A novel polymorphism in the promoter of the RAGE gene is associated with non-small cell lung cancer.

Schenk S, Schraml P, Bendik I, Ludwig CU.

Lung Cancer. 2001 Apr;32(1):7-12.

PMID:
11282423

Supplemental Content

Support Center